secwatch.observer — SEC 8-K summary
======================================

Issuer:     DNA X, Inc. (SONM)
CIK:        0001178697
Form:       8-K
Filed at:   2025-05-12T23:59:59+00:00
Accession:  0001641172-25-009689
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonim Q1 revenue $16.7M (+12% seq), GAAP net income $0.5M; adj EBITDA -$3.2M
----------------------------------------------------------------------------

- Net revenue $16.7M, +12% sequentially; GAAP net income $0.5M vs Q4 2024 loss of $21.6M.
- Adjusted EBITDA -$3.2M, improved from -$16.6M in Q4; cash $2.1M.
- Raised $6.5M via ATM and debt for expansion and European growth.
- XP Pro Thermal 5G orders, Verizon Frontline status, T-Mobile XP3plus launch targeting first responders.
- Set to launch five products in Q2 with Tier 1 carriers and distribution partners.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178697/000164117225009689/0001641172-25-009689-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178697/000164117225009689/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-009689

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer